Registry Studies

Descriptive Information

Benign prostatic hyperplasia (BPH) is one of the most commonly performed surgical procedures in urology. Over the past few decades, there has been an increasing development of new surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, the SIU is launching a prospective, ongoing international registry to obtain demographics and outcome data from patients undergoing surgical treatments for BPH.

1. To analyze demographic patterns and baseline characteristics of patients undergoing surgical treatments for BPH
2. To assess practice patterns (region-specific) for various surgical treatments for BPH
3. To assess key outcomes (efficacy and safety) for surgical treatments of BPH

1.  IPSS
2. QOL
3. Qmax
4. PVR
5. Complications (including incontinence)
   1. Type
   2. Clavien grade
6. SHIM, MSHQ-EJD (optional)

Recruitment Information

All patients >18 years old with a primary diagnosis of BPH with LUTS that are prescribed medical treatment or a surgical intervention.

• Patients >18 years old
• Symptomatic BPH with LUTS
•  Prescribed medication or surgical intervention for BPH

• Patients <18 years old
• Patient with no planned intervention

Centers/Contacts

Publications/Documents